Hydroxyurea, comparatively inexpensive and used as an anti-cancer agent, is also widely used in Sickle Cell Anemia but without a formal approval. CSIR-Sickle Cell Anemia Mission, coordinated by CCMB, has now approval from Drug Controller General of India to market hydroxyurea for Sickle Cell Anemia. This will be coupled with post-marketing surveillance.
|